` 301087 (Cofoe Medical Technology Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

301087
vs
S
Shanghai Composite

Over the past 12 months, Cofoe Medical Technology Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +78% compared to the Shanghai Composite's +27% growth.

Stocks Performance
301087 vs Shanghai Composite

Loading
301087
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
301087 vs Shanghai Composite

Loading
301087
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
301087 vs Shanghai Composite

Loading
301087
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Cofoe Medical Technology Co Ltd vs Peers

Shanghai Composite
301087
LEG
PMT
DFS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Cofoe Medical Technology Co Ltd
Glance View

Market Cap
12.1B CNY
Industry
Health Care

In the vibrant landscape of China's medical device industry, Cofoe Medical Technology Co Ltd emerges as a dynamic player, adeptly navigating the intersection of innovation and practicality. Founded with a mission to enhance healthcare accessibility, the company specializes in the design, production, and distribution of a broad spectrum of medical devices. From blood pressure monitors to thermometers, Cofoe's portfolio is tailored to meet the everyday health monitoring needs of consumers, hospitals, and clinics alike. The firm leverages its extensive research and development capabilities to stay ahead in a rapidly evolving market, ensuring its product offerings are both cutting-edge and user-friendly. Cofoe's business model is intricately woven around capturing value through both scale and precision. The company capitalizes on China's extensive manufacturing capabilities to produce cost-effective yet high-quality medical devices. It maintains a robust supply chain network that ensures efficiency and timely delivery. Moreover, Cofoe channels its marketing efforts through a mix of traditional retail outlets and burgeoning e-commerce platforms, effectively expanding its footprint both domestically and in selected international markets. By focusing on quality control, regulatory compliance, and customer satisfaction, Cofoe reinforces its brand reputation, thereby creating a sustainable competitive advantage and driving revenue growth.

Intrinsic Value
41.43 CNY
Overvaluation 28%
Intrinsic Value
Price ¥57.85
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett